Carolyn Grove

Dr. Carolyn Grove serves as a Clinical Associate Professor in the Department of Pathology & Laboratory Medicine at the UWA Medical School, The University of Western Australia. Her academic profile demonstrates active engagement in both clinical practice and research within the field of hematology and oncology.

Dr. Grove's research interests center on myeloid malignancies, with particular expertise in myeloproliferative neoplasms, myeloid leukemia, and acute myeloid leukemia. Her work spans molecular biology, genomics, and clinical therapeutics, focusing on targeted treatments for hematological malignancies. Recent publications highlight her involvement in cutting-edge clinical trials investigating novel therapies such as menin inhibitors and asciminib for various forms of leukemia.

Analysis of her recent publications reveals a consistent research trajectory toward developing targeted therapies for specific genetic subtypes of leukemia, with emphasis on KMT2A-rearranged and NPM1-mutated acute leukemias. Her work bridges basic science and clinical application, contributing to the advancement of precision medicine in hematological malignancies.

Dr. Grove has secured research funding through the Snowdome Foundation, serving as co-investigator on two significant projects: The Stewart Grant (Genomics Analysis Study) from February 2020 to February 2023, and the WA Lymphoma Centre of Research Excellence funding from July 2019 to September 2023. Her h-index of 12 with 653 citations reflects substantial scholarly impact in her field.

Her collaborative research network spans internationally, with numerous publications featuring co-authors from multiple countries, indicating strong professional connections within the global hematology research community. While specific laboratory details aren't provided in the available information, her research output suggests active participation in clinical research teams focused on hematological malignancies.